As Head of Commercial, Michael Newton is responsible for overseeing the Company’s entire U.S. commercialization strategy, including current products, new products and future services. He will lead the national sales force, driving adoption of the OVA1Plus product and establishing it as the standard of care for early risk detection of ovarian cancer, helping to achieve the goal of establishing Aspira as an industry leader in gynecologic health.

Michael joins Aspira from his role as Chief Commercial Officer at Insight Medical Genetics, a full-service genetic testing company focused on women’s health, where he led sales, marketing, training, and sales operations. Prior to that, he was the Chief Operating Officer at Legion Victrix Corp, and led sales and marketing at Shield Bio. Mr. Newton rose through the sales ranks at Roche Sequencing, where he served as regional business director promoting the Harmony NIPT Test, a genetic sequencing test for prenatal abnormalities. He began his career at Valeant Dermatology where he was the top-ranked sales director four years running. Mr. Newton holds a Bachelor of General Studies with minors in psychology, sociology, and English from the Louisiana State University.